Literature DB >> 1107014

Prolactin and growth hormone secretion in chemically induced and genetically obese mice.

Y N Sinha, C B Salocks, W P Vanderlaan.   

Abstract

Experiments were performed to determine PRL and GH concentrations in mice rendered obese by chemical means and to compare these concentrations with those of mice obese as a result of genetic mutation. Basal levels of serum PRL and GH were generally lower in gold thioglucose (GTG) and bipiperidyl mustard (BPM)-treated obese mice compared with lean controls. In the pituitary gland, the hormonal changes varied from lower or unchanged levels of PRL and GH shortly after drug injection to very high concentrations of PRL (but not of GH) a year later. However, when the mice were challenged with perphenazine, a drug that causes prompt release of PRL, GTG and BPM-obese mice released 2-5 times as much PRL as did lean controls, suggesting an impairment in the hypothalamic control of PRL secretion in GTG/BPM-obese mice. Basal levels of PRL and GH in genetically obese (ob/ob) mice of both sexes were also lower than those in their lean relatives (?/+). This was true for both serum and pituitary concentrations of the two hormones, the only exception being pituitary GH concentrations in females which were higher than or equal to those of controls. However, unlike GTG and BPM-obese mice, genetically obese mice released very little PRL compared with their lean relatives when stimulated with perphenazine, which suggested an insufficiency of pituitary function in ob/ob mice. The results demonstrate abnormalities in the secretion of PRL and GH in obese mice of both types.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1107014     DOI: 10.1210/endo-97-6-1386

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Hypothalamic leptin gene therapy reduces body weight without accelerating age-related bone loss.

Authors:  Russell T Turner; Michael Dube; Adam J Branscum; Carmen P Wong; Dawn A Olson; Xiaoying Zhong; Mercedes F Kweh; Iske V Larkin; Thomas J Wronski; Clifford J Rosen; Satya P Kalra; Urszula T Iwaniec
Journal:  J Endocrinol       Date:  2015-10-20       Impact factor: 4.286

2.  Hormonal changes during experimental hypothalamic obesity in rats.

Authors:  E V Epshtein; V V Bezrukov
Journal:  Neurosci Behav Physiol       Date:  1980 Mar-Apr

3.  Adipocyte versus pituitary leptin in the regulation of pituitary hormones: somatotropes develop normally in the absence of circulating leptin.

Authors:  Angela K Odle; Anessa Haney; Melody Allensworth-James; Noor Akhter; Gwen V Childs
Journal:  Endocrinology       Date:  2014-08-13       Impact factor: 4.736

4.  Adipocyte Versus Somatotrope Leptin: Regulation of Metabolic Functions in the Mouse.

Authors:  Angela Katherine Odle; Melody Allensworth-James; Anessa Haney; Noor Akhter; Mohsin Syed; Gwen V Childs
Journal:  Endocrinology       Date:  2016-02-09       Impact factor: 4.736

Review 5.  Metabolic actions of the growth hormone-insulin growth factor-1 axis and its interaction with the central nervous system.

Authors:  Omar Al-Massadi; Paolo Parini; Johan Fernø; Serge Luquet; Mar Quiñones
Journal:  Rev Endocr Metab Disord       Date:  2022-06-10       Impact factor: 9.306

6.  Inability of muscles in the obese mouse (ob/ob) to respond to changes in body weight and activity.

Authors:  N C Stickland; R A Batt; A R Crook; C M Sutton
Journal:  J Anat       Date:  1994-06       Impact factor: 2.610

7.  Pathophysiological differences between obese and non-obese spontaneously hypertensive rats.

Authors:  B C Wexler; S G Iams; J P McMurtry
Journal:  Br J Exp Pathol       Date:  1980-04

8.  Maintenance of obesity following hypophysectomy in the obese-hyperglycemic mouse (ob/ob).

Authors:  T A Plocher; T L Powley
Journal:  Yale J Biol Med       Date:  1977 May-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.